Table 4.
HIV-1 RNA Results |
|||||
---|---|---|---|---|---|
Total n=336 N (%) | Undetectable b n=159 n (%) | ≤ 832–1,499 copies/mL c n=120 n (%) | ≥ 1,500 copies/mL n=57 n (%) | p-value d | |
Drug use, n=336 | 0.271 | ||||
Non-drug users | 73 (21.7) | 30 (18.8) | 27 (22.5) | 16 (28.1) | |
Other drug users | 149 (44.4) | 76 (47.8) | 55 (45.8) | 18 (31.6) | |
Stimulant drug users | 114 (33.9) | 53 (33.3) | 38 (31.7) | 23 (40.4) | |
Age, n=336 | 0.398 | ||||
18 – 29 years | 69 (20.5) | 35 (21.9) | 26 (21.7) | 8 (14.0) | |
30 – 39 years | 116 (34.4) | 61 (38.1) | 35 (29.2) | 20 (35.1) | |
40 – 49 years | 91 (27.0) | 36 (22.5) | 35 (29.2) | 20 (35.1) | |
≥ 50 years | 61 (18.1) | 28 (17.5) | 24 (20.0) | 9 (15.8) | |
Race, n=336 | 0.720 | ||||
White | 239 (70.9) | 114 (71.3) | 87 (72.5) | 38 (66.7) | |
Black | 41 (12.2) | 19 (11.9) | 12 (10.0) | 10 (17.5) | |
Hispanic | 57 (16.9) | 27 (16.9) | 21 (17.5) | 9 (15.8) | |
Employment, n=335 e | <0.001 | ||||
Not working full time | 141 (42.1) | 58 (36.5) | 43 (36.1) | 40 (70.2) | |
Working full time | 194 (57.9) | 101 (63.5) | 76 (64.9) | 17 (29.8) | |
Income, n=330 e | 0.003 | ||||
< $20,000 | 107 (32.4) | 46 (29.1) | 34 (28.8) | 27 (50.0) | |
$20,000 - $59,999 | 142 (43.0) | 68 (43.0) | 50 (42.4) | 24 (44.4) | |
≥ $60,000 | 81 (24.6) | 44 (27.9) | 34 (28.8) | 3 (5.6) |
Notes: Column percentages presented; percentages may exceed 100% due to rounding.
A total of 337 participants provided a testable specimen. One participant with missing drug use data was excluded from all analyses.
An undetectable HIV-1 RNA result indicates that no HIV-1 RNA was detectable in the DBS specimen.
Individuals categorized in the ‘≤832–1,499 copies/mL’ group include individuals who had a qualitative (≤832 copies/mL) DBS HIV-1 RNA result and a quantitative DBS HIV-1 RNA result that ranged between 833 – 1,499 copies/mL.
Chi-square test.
Denominators vary due to missing data.